SMURF2 and cancer: Various studies have reported that miR‐503 can target SMURF1 and SMURF2 (SMAD ubiquitination regulation factors 1 and 2), thereby enhancing TGF‐β (transforming growth factor beta) signaling in individual biological processes other than cancer.42, 43